New research shows that two common drugs for type 2 diabetes may not provide the same benefits for Black individuals. Cardiovascular disease and kidney problems are major complications of type 2 diabetes. The study reveals that these drugs, sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) and glucagon-like peptide 1 receptor agonists (GLP1-RAs), help reduce the risk of … Read more